Device Trial Radar · NCT06360380
Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System
Last checked: Nov 19, 2026Latest source record: Nov 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
40
Planned (sponsor's estimate)
Start
Aug 12, 2024
Primary completion
Jul 23, 2026
Study completion Apr 2027
Sponsor
- Lead sponsor
- AquaPass Medical Ltd.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Apr 11, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 21 years, up to 79 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The REFORM-HF study aims to test a new technology, AQUAPASS, designed to assist patients experiencing symptoms of fluid overload due to Heart Failure. Patients will wear a lightweight suit that helps remove excess fluids through their sweat. The investigators want to see if the AQUAPASS system can remove an additional 500mL of fluids during treatment, alongside patients' regular medications like diuretics. Participants will be treated in the hospital or in the outpatient clinic.
Conditions
- Chronic Heart Failure
- CKD Stage 3
Interventions
AquaPass SystemDevice
a treatment session of up to 5 hours with the AquaPass system, evaluating net fluid removal for efficacy analysis and effect on vital signs for safety analysis
Primary outcomes
What the sponsor says the trial is designed to measure.
- AQUAPASS Performance EvaluationTime frame: 5 days
Locations
10 sites in 2 countries. Site status is shown where the registry gives one.
UC San Diego Health-Sulpizio Cardiovascular Center
La Jolla, California · Recruiting
UC San Francisco
San Francisco, California · Recruiting
University of Minnesota
Minneapolis, Minnesota · Recruiting
7 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.